The outlook change reflects Moody’s Investors Service’s uncertainty about the outcome of CHS’ strategic review.
Moody’s also affirmed CHS’ existing ratings, including its “B2” corporate family rating and “B2-PD” probability of default rating.
The actions follow CHS’ announcement that it is exploring a variety of options with financial sponsors.
More articles on healthcare finance:
West Virginia has saved more than $1M by enrolling inmates in Medicaid
AdvantEdge Healthcare Solutions achieves recertification for HIPAA and HITECH conformity
Spotlight Innovation reveals debt restructuring plan
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.